Table 2 Implementation of functions assessed
Function | # Sub-indicators | Implementation of sub-indicators | |||
|---|---|---|---|---|---|
Fully | Partially | Ongoing | Not | ||
Registration and marketing authorization (MA) | 35 | 29 (83%) | 4 (11%) | 0 (0%) | 2 (6%) |
Laboratory testing (LT) | 28 | 23 (82%) | 0 (0%) | 2 (7%) | 3 (11%) |
Licensing establishments (LI) | 19 | 15 (79%) | 0 (0%) | 1 (5%) | 3 (16%) |
Vigilance (VL) | 26 | 20 (77%) | 4 (15%) | 0 (0%) | 2 (8%) |
Market Surveillance and Control (MC) | 27 | 20 (74%) | 2 (7%) | 0 (0%) | 5 (19%) |
Clinical Trials Oversight (CT) | 30 | 19 (63%) | 3 (10%) | 5 (17%) | 3 (10%) |
National Regulatory System (RS) | 60 | 37 (62%) | 4 (6%) | 0 (0%) | 19 (32%) |
Regulatory inspection (RI) | 26 | 16 (62%) | 0 (0%) | 1 (4%) | 9 (34%) |